Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
The first CAR T therapy has now been approved for use in multiple myeloma. Learn more about the exciting new therapy, Abecma.
What's coming in 2021 for multiple myeloma patients? Dr. Robert Orlowski joins our annual Myeloma Crowd Radio show.
How does COVID-19 affect multiple myeloma patients in the short and long-term? Dr. Ghobrial shares her IMPACT study.
Where are we at more than seven months into the COVID situation? Dr. Richter helps myeloma patients understand the landscape.
How venetoclax is being used as myeloma's first precision-medicine treatment for 11;14 multiple myeloma patients
Learn more about a myeloma vaccine to extend remissions for previously treated patients
How can patients use integrative or alternative therapies in their multiple myeloma care?
Direct-to-drug screening can help tailor myeloma therapy for each patient type
Isatuximab is a new CD38 monoclonal antibody in the myeloma clinic
What's here (and coming) for myeloma patients? Learn from this important mid-year ASCO update with Dr. Paul Richardson of Dana Farber